The Tennessee Titans' social media and video production teams continue to win on NFL schedule release day. The team's 2025 schedule video is a deft commercial spoof, titled "Schedule-rizi ...

AbbVie’s Skyrizi is approved by the FDA for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease.

New products Skyrizi and Rinvoq help AbbVie cope with accelerating erosion of Humira sales from biosimilar competition in 2023.

AbbVie expects combined sales of Skyrizi and Rinvoq to be around $24.7 billion in 2025 and more than $31 billion by 2027.

The version of the Republican megabill passed by the House last month includes a provision that ends an effort to get 1099-K tax forms out to workers or sellers who have earned more than $600 a year.

Today, AbbVie's product lineup includes two successors to Humira, Rinvoq and Skyrizi, that should rake in combined sales of $31 billion by 2027.

Walmart’s ‘relaxing, modern’ patio set was $600, but you can get it for $200 this week Courtesy of Walmart ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Ross Chastain came all the way from the back of the field to overtake William Byron in the final stage to win the Coca-Cola 600 on Sunday at Charlotte Motor Speedway.

The deal aims to strengthen AbbVie's already strong position in immunology, building on the success of autoimmune treatments Skyrizi and Rinvoq, which are expected to generate over $31 billion in ...

Cimzia (certolizumab pegol) is a prescription injection that treats Crohn’s disease, arthritis, and other conditions. Learn about side effects, dosage, and more.

Acyclovir comes in several prescription forms, including an oral tablet. The acyclovir oral tablet is used to treat viral infections like shingles, genital herpes, and chickenpox. This form is ...